Drew Gantt has joined Cooley LLP’s Washington DC office to work as head of the firm’s healthcare regulatory practice. Gantt comes from Latham & Watkins LLP, where he worked as a healthcare and life sciences partners. He has experience advising VCs and PE funds on regulatory issues pertaining to healthcare deals.
Leading Health Care Regulatory Attorney Joins Cooley
Washington, DC – June 16, 2011 – Cooley LLP announced that W. Andrew (“Drew”) H. Gantt III has joined the firm as a partner. He will be resident in Cooley’s Washington, DC office and will head the firm’s Health Care Regulatory practice. Gantt was previously a health care and life sciences partner in the Washington, DC office of Latham & Watkins LLP.
Gantt represents a wide variety of health care and life sciences companies, health plans, health care providers, manufacturers, suppliers, health care IT, communications, and “eHealth” companies in corporate and regulatory matters. In addition, he advises venture capital groups, private equity funds and other investors and financial groups on health care regulatory issues in connection with the financing of health care mergers and acquisitions, securities offerings and financings. Gantt has been recommended as a Health Care and Life Sciences attorney by The Legal 500.
Recently recognized as one of the top 10 outstanding health care IT lawyers by Nightingale’s Healthcare News, Gantt has a particular expertise in advising health care and life sciences companies on eHealth, health care data privacy and security matters, as well as on compliance with Federal and state fraud and abuse laws. He also is chair of the ABA eHealth, Privacy & Security Interest Group.
“Drew is a key addition to our firmwide life sciences practice and will be an important resource for our large base of life sciences companies, many of whom will increasingly face health care regulatory issues,” said Eric Jensen, chair of Cooley’s Business department. “We are very pleased to welcome Drew and look forward to continuing to augment our expertise in this key area.”
“Cooley’s leadership in life sciences and technology is undisputed, and I look forward to expanding its health care regulatory practice at a time when this expertise is increasingly in demand,” said Gantt. “There has never been a time when health care and life sciences companies have been subject to greater regulatory scrutiny than they are today, and I look forward to helping these companies navigate the complex regulatory issues they face.”
Gantt earned his a BA from University of California-Berkeley in 1987, a MTS from Harvard Divinity School in 1990, and his JD from the University of Virginia in 1993. Prior to joining Latham, Gantt was associate general counsel with Johns Hopkins Health Systems. He is admitted to practice in Maryland and the District of Columbia.
Cooley ranked #1 in Life Sciences by Chambers USA: America’s Leading Lawyers for Business in 2007- 2010 and has ranked #1 for issuer-side initial public offerings in the biotech and pharmaceutical sectors from 2004-2010 (IPO Vital Signs).
About Cooley LLP
Cooley’s 650 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients’ most challenging legal matters. From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today’s global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, venture capital, clean energy, real estate and retail.
The firm has full-service offices in major business and technology centers across the United States: Palo Alto, CA, New York, NY, San Diego, CA, San Francisco, CA, Reston, VA, Broomfield, CO, Washington, DC, Boston, MA and Seattle, WA.